pharmaphorum

JANUARY 17, 2022

A World Health Organization (WHO) panel has given the green light to two new drugs to treat COVID-19. It prevents the overstimulation of the immune system and is said to improve survival and reduce the need for ventilation in covid-19 patients, with no observed increase in adverse effects.

Hospitals 112

Hospitals Diabetes Immunity Immunization 112

pharmaphorum

AUGUST 10, 2020

Drugmakers have been working with data specialist Certara on a new tool that they hope could speed up the development of vaccines for COVID-19. The database builds on a COVID-19 pharmacology resource that was launched by Certara in April to provide pharmacology simulation tools and a forum for scientific exchange.

Vaccines 105

Vaccines Drug Development 105

Pharmacy Joe

JUNE 14, 2020

In this episode, I’ll discuss an article about hydroxychloroquine for prophylaxis after high-risk Covid-19 exposure. Episode 513: Does hydroxychloroquine work for prophylaxis after high-risk Covid-19 exposure? Nearly 90% reported a high-risk exposure to a confirmed Covid-19 contact.

Adverse Reactions 40

Adverse Reactions Inpatient 40

Pharmacy Joe

MAY 17, 2020

In this episode, I’ll discuss a new observation study on hydroxychloroquine and Covid-19. Unfortunately beyond these small reports and in vitro data, little information exists on this topic. Nearly 60% received hydroxychloroquine. The remaining 1376 patients, had a median follow-up of 22.5

Hospitals 40

Hospitals Inpatient 40